Health Care: Drugs

Salix Pharmaceuticals Ltd (SLXP: NASDAQ)

$143.85 -0.65 | -0.45%
10/31/14 - 04:00 PM ET
Company Income Statement
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Sales 933.84M 735.44M 540.49M 336.97M
Cost of Sales 134.66M 86.14M 73.75M 90.26M
Gross Operating Profit 799.18M 649.30M 466.74M 246.71M
Selling, General, and Administrative Expenses 304.22M 258.19M 186.99M 156.10M
Research & Development 149.97M 123.23M 104.35M 73.35M
Operating Income before D & A (EBITDA) 344.99M 267.88M 175.40M 17.26M
Depreciation & Amortization 89.47M 83.80M 32.52M 23.44M
Interest Income 2.00M 10.85M 2.35M 2.63M
Other Income - Net 16.20M 14.02M -27.00M 0.00
Special Income / Charges -16.20M -71.20M 0.00 0.00
Total Income Before Interest Expenses (EBIT) 273.72M 167.35M 118.22M -3.55M
Interest Expense 61.65M 55.52M 32.12M 20.65M
Pre-Tax Income 212.06M 111.83M 86.10M -24.20M
Income Taxes 69.03M 47.58M -1.30M 2.86M
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations 143.03M 64.25M 87.40M -27.06M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations 143.03M 64.25M 87.40M -27.06M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 143.03M 64.25M 87.40M -27.06M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
143.03M 105.85M 87.40M -27.06M
Preferred Dividends
Net Income Available To Common 143.03M 64.25M 87.40M -27.06M
Basic EPS from Continuing Ops. 2.31 1.09 1.49 -0.47
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations 2.31 1.09 1.49 -0.47
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total 2.31 1.09 1.49 -0.47
Basic Normalized Net Income/Share 2.31 1.80 1.49 -0.47
EPS fr Continuing Ops. 2.18 1.01 1.33 -0.47
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. 2.18 1.01 1.33 -0.47
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.11 0.00
EPS, Total 2.18 1.01 1.44 -0.47
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
2.18 1.66 1.33 -0.47
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with SLXP

Latest SLXP Headlines from TheStreet

More Financial News for SLXP

Press Releases for SLXP

See All Press Releases

Partner Headlines for SLXP

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter